Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zane He

Psychiatry Columbia, MO Medical Doctor

NPI 1750949541 CMS profile 6879758

909 Hitt St, Columbia, MO 65211

Open in the dashboard

General payments

$5,372

113 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zane He of Columbia, MO is reported in the CMS Open Payments database as having received $5,372 across 113 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $573 7
2024 General $292 3
2023 General $713 10
2022 General $1,837 67
2021 General $1,014 14
2020 General $358 5
2019 General $585 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zane He
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Zane He were reported at $573. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Zane He Psychiatry median Middle half National median
2019 $585 $184 $59–$605 $163
2020 $358 $119 $36–$372 $114
2021 $1,014 $143 $43–$576 $132
2022 $1,837 $153 $50–$590 $149
2023 $713 $170 $56–$651 $160
2024 $292 $179 $57–$673 $164
2025 $573 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $1,574 26 payments
  2. Alkermes, Inc. $1,030 20 payments
  3. Otsuka America Pharmaceutical, Inc. $507 10 payments
  4. Neurocrine Biosciences, Inc. $455 10 payments
  5. AbbVie, Inc. $430 11 payments
  6. ITI, Inc. $399 12 payments
  7. Teva Pharmaceuticals USA, Inc. $241 4 payments
  8. Axsome Therapeutics, Inc. $206 2 payments
  9. Corium, Inc. $146 4 payments
  10. E.R. Squibb & Sons, L.L.C. $104 1 payment
  11. Other $279 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,372 113 payments
Products named General payments · program years 2019–2025
  1. INVEGA SUSTENNA $1,289 21 payments
  2. ARISTADA INITIO $751 15 payments
  3. ARISTADA Cns $751 15 payments
  4. ARISTADA Cns $751 15 payments
  5. ARISTADA Cns $688 10 payments
  6. ARISTADA Cns $688 10 payments
  7. SPRAVATO $535 7 payments
  8. VRAYLAR $430 11 payments
  9. ABILIFY MAINTENA $417 9 payments
  10. CAPLYTA $399 12 payments
  11. Other $3,126 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record